Genetic Testing Referral Rates for Pheochromocytoma and Paraganglioma in an Academic Tertiary Centre
Germline testing was performed in less than half of patients with PPGL, and 30% who underwent tested carried a pathogenic mutation, reinforcing the importance of genetics evaluation. Older age, Medicare coverage, and head and neck paragangliomas were associated with lower rates of genetic testing, presenting opportunities to improve education and equity in the management of patients with PPGL.
Authors
- Run Yu (ORCID: https://orcid.org/0000-0003-2901-5102)
- Na Eun Kim (ORCID: https://orcid.org/0000-0002-7896-9458)
- Dipti P. Sajed
- Elena G Hughes (ORCID: https://orcid.org/0000-0002-7803-1240)
- Brian Ruhle (ORCID: https://orcid.org/0000-0001-9056-7753)
- Michael W. Yeh (ORCID: https://orcid.org/0000-0001-7907-4245)
- Masha J. Livhits (ORCID: https://orcid.org/0000-0002-8436-392X)
- James X. Wu (ORCID: https://orcid.org/0000-0001-5090-7573)
- Sang Ngo
Institutions
- University of California, Los Angeles (US)
- Kaiser Permanente Baldwin Park Medical Center (US)
- Stanford University (US)
Publication Details
- Journal
- Clinical Endocrinology
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1111/cen.15248
- Citations
- 1
- Primary Topic
- Adrenal and Paraganglionic Tumors
- Type
- article
- Field-Weighted Citation Impact
- 2.01